Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment of a human pluripotent stem cell-derived sensory neuron platform for studying diabetes-associated metabolic and oxidative stress-induced neuronal injury. | J Neurosci Methods | 2027 | 42826868 | PubTator, text mining | PubMed |
| Discovery and Characterization of Neuroactive Secondary Metabolites from Acacia sieberiana with Potential Analgesic Properties. | ACS Omega | 2026 | 42819829 | PubTator, text mining | PubMed |
| Peripheral NaV1.7 modulation reveals divergent peripheral and central adaptations in persistent trigeminal pain. | bioRxiv | 2026 | 42818013 | PubTator, text mining | PubMed |
| Chasing the Wrong Door for 30 Years: Is Suzetrigine the Key to Selective Pain Relief? | Medicina (Kaunas) | 2026 | 42796305 | PubTator, text mining | PubMed |
| Pharmacological modulation of peripheral nerve excitability: a novel way to investigate sodium channel subtypes in humans. | Pain | 2026 | 42751727 | PubTator, text mining | PubMed |
| Deeper delving Nav1.8 inhibitor Suzetrigine in chronic pain. | Acta Pharmacol Sin | 2026 | 42745014 | PubTator, text mining | PubMed |
| Investigating genetic susceptibility to concussion through rare variants in ion channel and neurotransmission genes. | J Neurol | 2026 | 42730919 | PubTator, text mining | PubMed |
| Ion-Channel Activity of Characteristic Alkaloids From Uncaria rhynchophylla. | Chem Biodivers | 2026 | 42720106 | PubTator, text mining | PubMed |
| Antigen-Detected NMR for Minimal Epitope Engineering and Structure-Guided Selection of a NaV1.7-Selective Nanobody. | Adv Sci (Weinh) | 2026 | 42702812 | PubTator, text mining | PubMed |
| Pain Management in Erythromelalgia: A Systematic Review and Graded Appraisal Across Etiological Subtypes. | Eur J Pain | 2026 | 42695143 | PubTator, text mining | PubMed |
| A designer saxitoxin-engineered sodium channel pair as a general tool for subtype-selective inhibition. | Cell Chem Biol | 2026 | 42679814 | PubTator, text mining | PubMed |
| Human α1-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain. | Biomolecules | 2026 | 42650742 | PubTator, text mining | PubMed |
| Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review. | Drug Metab Pers Ther | 2026 | 42639659 | PubTator, text mining | PubMed |
| Pharmacogenomics in Dentistry: From CYP-Mediated Drug Response to Precision Prescribing in Oral Healthcare. | Oral Dis | 2026 | 42630019 | PubTator, text mining | PubMed |
| Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad. | Annu Rev Pharmacol Toxicol | 2026 | 42594287 | PubTator, text mining | PubMed |
| Blended Hereditary Neuropathy Phenotype Caused by Biallelic PRX and SCN9A Variants: A Case Report. | Mol Syndromol | 2026 | 42583656 | PubTator, text mining | PubMed |
| Functional characterization of human iPSC-derived sensory neuron processes in microfluidic cultures. | Stem Cells Transl Med | 2026 | 42571974 | PubTator, text mining | PubMed |
| Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors. | J Comput Aided Mol Des | 2026 | 42563012 | PubTator, text mining | PubMed |
| Transcriptomic comparison of the infrapatellar fat pad between young patients with traumatic knee injury and older patients with knee osteoarthritis. | Connect Tissue Res | 2026 | 42560660 | PubTator, text mining | PubMed |
| Gene variants associated with pediatric-onset erythromelalgia: Mendelian and rare-variant association analyses. | Pain Rep | 2026 | 42559536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers